Skip to main content
. Author manuscript; available in PMC: 2016 Aug 2.
Published in final edited form as: Expert Rev Mol Diagn. 2015 Aug 2;15(10):1293–1310. doi: 10.1586/14737159.2015.1071666

Table 2.

Tumor associated proteins in EVs/exosomes derived from human tumor cell linesa

Not cell-type specificb EV cell source Biological effects Reference

  Tetraspanins: CD9, CD63, CD81 Normal or tumor cells Exosome sorting 134, 135
  Heat shock proteins: Hsp70, HSP90 Various tumor cells Exosome antigenicity 54,136
  Biogenesis associated: TSG-101, ALIX Normal or tumor cells Exosome formation 26, 136
Membrane transport: anexins, flotellin, caveolin-1, Rab GTPase Normal or tumor cells Exosome release 137, 138, 139
  Immune cell apoptosis FasL, TRAIL, galectin-9 Various tumor cells Immune suppression by exosomes 32, 34, 35 124, 140

Cancer cell-associatedc Tumor type Pro-tumor effects Reference

Amplified oncogenes (K-ras mut) CRC Oncogene transfer 4044
EGFRVIII mut GBM Growth 141, 142
IDH1, IDH2 mut GBM, meduloblastoma Growth, invasion 141, 143, 144
Amphiregulin BRCA, CRC Growth, invasion 145
Survivin Inhibits apoptosis 146
GD2 ganglioside NB Immune suppression 146
FGF-2 Meduloblastoma Growth 143
LMP-1 NPC Signal Transduction 148
MUC-1 BRCA Growth, invasion 149
Del-1 Mesothelioma Angiogenesis 143
EpCAM CRC Growth, invasion 96
TGF-β GBM, BRCA Immune Suppression 142
Mesothelioma Stroma remodeling 61, 62
VEGF, TIMP 1, MMP-9 GBM Growth, invasion, stroma 44

Abbreviations: GBM, glioblastoma multiforme; med bl, medulloblastoma; BRCA, breast carcinoma; NB, neuroblastoma; NPC, nasopharyngeal carcinoma; CRC, colorectal cancer.

a

EVs were isolated from supernatants of tumor cell lines by various methods, without discrimination of larger EVs from smaller exosomes.

b

The proteins listed are present in EVs isolated from tumor cells at higher levels compared to those observed in EVs obtained from normal cells.

c

The list of proteins is selected from more than 10,000 proteins listed in the EVpedia database [150] and Vesiclepedia [151]

HHS Vulnerability Disclosure